JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
PHAT Financials - Phathom Pharmaceuticals Income & Cash Flow | Ledgeburg
PHAT - Phathom Pharmaceuticals, Inc.
USD | NASDAQ | Healthcare
Summary
Summary PHAT Stock
Financials
Financials PHAT Stock
Loading...
Loading...
Income Statement
Income Statement PHAT Stock
Balance Sheet
Balance Sheet PHAT Stock
Cash Flow Statement
Cash Flow Statement PHAT Stock
Loading...
Loading...
Home
Stocks
Phathom Pharmaceuticals, Inc. (PHAT)
Financials
Financials of PHAT
Loading...
Loading...
Loading...
Loading...
Revenue
$175.11M
Operating Income
$-159.986M
Net Income
$-221.247M
Share Count (Basic)
72.918764M
Operating Cash Flow
$-166.775M
Free Cash Flow
$-167.004M
Cash And Short-Term Equivalents
$129.972M
Total Debt
$209.087M
Annual
Quarterly
Revenue $USD
0
50M
100M
150M
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
20M
40M
60M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-300M
-250M
-200M
-150M
Annual
Quarterly
Margins
Gross
Operating
Net
-30000%
-20000%
-10000%
0%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-100M
-80M
-60M
-40M
-20M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-300%
-200%
-100%
0%
100%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26